ASIX · AdvanSix Inc. Common Stock
View on chartInsiders & Stakes
| Erin N. Kane Chief Executive Officer | ▼ Sell | Tax Withholding | 623,103 Shares held | 2/28/2026 | View profile |
| Preston Michael SVP & Chief Financial Officer | ▲ Buy | Grant | 165,410 Shares held | 2/28/2024 | View profile |
| Marberry Michael Director | ▲ Buy | Grant | 128,262 Shares held | 3/31/2023 | View profile |
| Todd D. Karran Director | ▲ Buy | Grant | 91,946 Shares held | 6/22/2026 | View profile |
| Sharon Spurlin Director | ▲ Buy | Grant | 80,953 Shares held | 6/22/2026 | View profile |
| Christopher Gramm Controller | ▼ Sell | Tax Withholding | 73,025 Shares held | 2/28/2026 | View profile |
| Kelly Slieter SVP, Chief HR Officer | ▼ Sell | Tax Withholding | 65,029 Shares held | 2/28/2026 | View profile |
| Achilles B. Kintiroglou SVP, General Counsel | ▼ Sell | Tax Withholding | 50,363 Shares held | 2/28/2026 | View profile |
| Patrick Williams Director | ▲ Buy | Grant | 44,219 Shares held | 10/6/2026 | View profile |
| Manjeshwar Siddharth SVP & Chief Financial Officer | ▲ Buy | Grant | 40,852 Shares held | 2/28/2025 | View profile |
| Patrick C. Day SVP, CFO | ▲ Buy | Grant | 38,038 Shares held | 4/27/2026 | View profile |
| Hughes Darrell K. Director | ▲ Buy | Grant | 37,769 Shares held | 6/11/2024 | View profile |
| Daniel F. Sansone Director | ▲ Buy | Grant | 36,288 Shares held | 6/18/2025 | View profile |
| Blindenbach Willem L. SVP, Integrated Supply Chain | ▲ Buy | Grant | 26,998 Shares held | 2/28/2022 | View profile |
| Donald P. Newman Director | ▲ Buy | Grant | 21,513 Shares held | 6/22/2026 | View profile |
| Gena C. Lovett Director | ▲ Buy | Grant | 21,369 Shares held | 6/22/2026 | View profile |
| Rachael E. Ryan VP, Controller | ▼ Sell | Tax Withholding | 16,513 Shares held | 3/24/2026 | View profile |
| Farha Aslam Director | ▲ Buy | Grant | 10,082 Shares held | 6/11/2024 | View profile |
| Jeffrey J. Bird President & COO | ▲ Buy | Grant | 6,207 Shares held | 6/22/2026 | View profile |
| Dana C. O'Brien Director | ▲ Buy | Grant | 6,207 Shares held | 6/22/2026 | View profile |
| Daryl Roberts Director | ▲ Buy | Grant | 6,207 Shares held | 6/22/2026 | View profile |
Transaction History
| Patrick Williams | ▲ Buy | Grant | 785 | $13K | 10/6/2026 |
| Patrick Williams | ▲ Buy | Grant | 660 | $13K | 6/30/2026 |
| Jeffrey J. Bird | ▲ Buy | Grant | 6,207 | $0 | 6/22/2026 |
| Todd D. Karran | ▲ Buy | Grant | 6,207 | $0 | 6/22/2026 |
| Gena C. Lovett | ▲ Buy | Grant | 6,207 | $0 | 6/22/2026 |
| Donald P. Newman | ▲ Buy | Grant | 6,207 | $0 | 6/22/2026 |
| Dana C. O'Brien | ▲ Buy | Grant | 6,207 | $0 | 6/22/2026 |
| Daryl Roberts | ▲ Buy | Grant | 6,207 | $0 | 6/22/2026 |
| Sharon Spurlin | ▲ Buy | Grant | 6,207 | $0 | 6/22/2026 |
| Patrick Williams | ▲ Buy | Grant | 6,207 | $0 | 6/22/2026 |
| Patrick C. Day | ▲ Buy | Grant | 19,019 | $450K | 4/27/2026 |
| Patrick C. Day | ▲ Buy | Grant | 19,019 | $450K | 4/27/2026 |
| Patrick Williams | ▲ Buy | Grant | 537 | $13K | 3/31/2026 |
| Rachael E. Ryan | ▼ Sell | Tax Withholding | 2,074 | $46K | 3/24/2026 |
| Achilles B. Kintiroglou | ▼ Sell | Tax Withholding | 8,008 | $140K | 2/28/2026 |
| Kelly Slieter | ▼ Sell | Tax Withholding | 5,424 | $95K | 2/28/2026 |
| Erin N. Kane | ▼ Sell | Tax Withholding | 33,642 | $588K | 2/28/2026 |
| Christopher Gramm | ▼ Sell | Tax Withholding | 2,624 | $46K | 2/28/2026 |
| Rachael E. Ryan | ▲ Buy | Grant | 5,621 | $100K | 2/26/2026 |
| Achilles B. Kintiroglou | ▲ Buy | Grant | 28,106 | $500K | 2/26/2026 |
| Kelly Slieter | ▲ Buy | Grant | 22,485 | $400K | 2/26/2026 |
| Christopher Gramm | ▲ Buy | Grant | 21,079 | $375K | 2/26/2026 |
| Erin N. Kane | ▲ Buy | Grant | 111,298 | $2.0M | 2/26/2026 |
| Donald P. Newman | ▲ Buy | Grant | 1,721 | $27K | 12/15/2025 |
| Patrick Williams | ▲ Buy | Grant | 821 | $13K | 12/15/2025 |
| Achilles B. Kintiroglou | ▼ Sell | Open Market | 577 | $12K | 10/3/2025 |
| Patrick Williams | ▲ Buy | Grant | 677 | $13K | 9/30/2025 |
| Donald P. Newman | ▲ Buy | Grant | 1,418 | $27K | 9/30/2025 |
| Achilles B. Kintiroglou | ▼ Sell | Open Market | 571 | $12K | 9/2/2025 |
| Achilles B. Kintiroglou | ▼ Sell | Open Market | 571 | $12K | 8/1/2025 |
| Achilles B. Kintiroglou | ▼ Sell | Open Market | 571 | $14K | 7/2/2025 |
| Patrick Williams | ▲ Buy | Grant | 552 | $13K | 6/30/2025 |
| Donald P. Newman | ▲ Buy | Grant | 977 | $23K | 6/30/2025 |
| Patrick Williams | ▲ Buy | Grant | 5,020 | $0 | 6/18/2025 |
| Sharon Spurlin | ▲ Buy | Grant | 5,020 | $0 | 6/18/2025 |
| Daniel F. Sansone | ▲ Buy | Grant | 5,020 | $0 | 6/18/2025 |
| Donald P. Newman | ▲ Buy | Grant | 5,020 | $0 | 6/18/2025 |
| Gena C. Lovett | ▲ Buy | Grant | 5,020 | $0 | 6/18/2025 |
| Todd D. Karran | ▲ Buy | Grant | 5,020 | $0 | 6/18/2025 |
| Achilles B. Kintiroglou | ▼ Sell | Open Market | 571 | $14K | 6/2/2025 |
| Achilles B. Kintiroglou | ▼ Sell | Open Market | 3,237 | $69K | 5/1/2025 |
| Achilles B. Kintiroglou | ▼ Sell | Open Market | 4,000 | $89K | 4/1/2025 |
| Patrick Williams | ▲ Buy | Grant | 579 | $13K | 3/31/2025 |
| Donald P. Newman | ▲ Buy | Grant | 993 | $22K | 3/31/2025 |
| Rachael E. Ryan | ▲ Buy | Grant | 8,644 | $0 | 3/24/2025 |
| Rachael E. Ryan | ▲ Buy | Grant | 4,322 | $0 | 3/24/2025 |
| Achilles B. Kintiroglou | ▼ Sell | Open Market | 4,000 | $111K | 3/3/2025 |
| Kelly Slieter | ▲ Buy | Grant | 12,073 | $0 | 2/28/2025 |
| Christopher Gramm | ▼ Sell | Tax Withholding | 1,934 | $54K | 2/28/2025 |
| Christopher Gramm | ▲ Buy | Grant | 9,010 | $0 | 2/28/2025 |
| Erin N. Kane | ▼ Sell | Tax Withholding | 22,213 | $616K | 2/28/2025 |
| Erin N. Kane | ▲ Buy | Grant | 64,865 | $0 | 2/28/2025 |
| Achilles B. Kintiroglou | ▲ Buy | Grant | 15,856 | $0 | 2/28/2025 |
| Manjeshwar Siddharth | ▲ Buy | Grant | 14,415 | $0 | 2/28/2025 |
| Kelly Slieter | ▼ Sell | Tax Withholding | 3,319 | $92K | 2/28/2025 |
| Achilles B. Kintiroglou | ▼ Sell | Tax Withholding | 4,731 | $131K | 2/28/2025 |
| Christopher Gramm | ▲ Buy | Grant | 3,982 | $0 | 2/28/2025 |
| Erin N. Kane | ▼ Sell | Open Market | 600 | $18K | 2/3/2025 |
| Erin N. Kane | ▼ Sell | Open Market | 4,400 | $133K | 2/3/2025 |
| Erin N. Kane | ▼ Sell | Open Market | 4,700 | $132K | 1/2/2025 |
| Erin N. Kane | ▼ Sell | Open Market | 300 | $9K | 1/2/2025 |
| Todd D. Karran | ▲ Buy | Grant | 1,559 | $47K | 12/16/2024 |
| Patrick Williams | ▲ Buy | Grant | 430 | $13K | 12/16/2024 |
| Erin N. Kane | ▼ Sell | Open Market | 5,000 | $161K | 12/2/2024 |
| Christopher Gramm | ▲ Buy | Option Exercise | 1,951 | $28K | 11/25/2024 |
| Christopher Gramm | ▼ Sell | Open Market | 1,951 | $62K | 11/25/2024 |
| Donald P. Newman | ▲ Buy | Open Market | 5,030 | $149K | 11/18/2024 |
| Christopher Gramm | ▲ Buy | Option Exercise | 505 | $7K | 11/7/2024 |
| Christopher Gramm | ▼ Sell | Open Market | 505 | $16K | 11/7/2024 |
| Christopher Gramm | ▼ Sell | Open Market | 2,435 | $78K | 11/6/2024 |
| Christopher Gramm | ▲ Buy | Option Exercise | 2,435 | $35K | 11/6/2024 |
| Erin N. Kane | ▼ Sell | Open Market | 3,500 | $106K | 11/1/2024 |
| Erin N. Kane | ▼ Sell | Open Market | 1,500 | $46K | 11/1/2024 |
| Achilles B. Kintiroglou | ▼ Sell | Open Market | 363 | $11K | 11/1/2024 |
| Christopher Gramm | ▲ Buy | Option Exercise | 270 | $4K | 10/4/2024 |
| Christopher Gramm | ▼ Sell | Open Market | 270 | $9K | 10/4/2024 |
| Manjeshwar Siddharth | ▲ Buy | Grant | 26,437 | $0 | 10/1/2024 |
| Erin N. Kane | ▼ Sell | Open Market | 5,000 | $151K | 10/1/2024 |
| Achilles B. Kintiroglou | ▼ Sell | Open Market | 350 | $11K | 10/1/2024 |
| Todd D. Karran | ▲ Buy | Grant | 1,564 | $48K | 9/30/2024 |
| Patrick Williams | ▲ Buy | Grant | 432 | $13K | 9/30/2024 |
| Erin N. Kane | ▼ Sell | Open Market | 4,900 | $138K | 9/3/2024 |
| Erin N. Kane | ▼ Sell | Open Market | 100 | $3K | 9/3/2024 |
| Achilles B. Kintiroglou | ▼ Sell | Open Market | 350 | $10K | 9/3/2024 |
| Christopher Gramm | ▲ Buy | Option Exercise | 5,213 | $74K | 8/23/2024 |
| Christopher Gramm | ▼ Sell | Open Market | 5,213 | $156K | 8/23/2024 |
| Erin N. Kane | ▼ Sell | Open Market | 3,442 | $96K | 8/2/2024 |
| Erin N. Kane | ▼ Sell | Open Market | 1,558 | $43K | 8/1/2024 |
| Achilles B. Kintiroglou | ▼ Sell | Open Market | 350 | $10K | 8/1/2024 |
| Erin N. Kane | ▼ Sell | Open Market | 8,079 | $225K | 7/31/2024 |
| Erin N. Kane | ▼ Sell | Open Market | 6,921 | $193K | 7/30/2024 |
| Achilles B. Kintiroglou | ▼ Sell | Open Market | 350 | $8K | 7/1/2024 |
| Patrick Williams | ▲ Buy | Grant | 572 | $13K | 6/28/2024 |
| Todd D. Karran | ▲ Buy | Grant | 2,072 | $47K | 6/28/2024 |
| Farha Aslam | ▲ Buy | Grant | 4,393 | $0 | 6/11/2024 |
| Hughes Darrell K. | ▲ Buy | Grant | 4,393 | $0 | 6/11/2024 |
| Patrick Williams | ▲ Buy | Grant | 4,393 | $0 | 6/11/2024 |
| Gena C. Lovett | ▲ Buy | Grant | 4,393 | $0 | 6/11/2024 |
| Todd D. Karran | ▲ Buy | Grant | 4,393 | $0 | 6/11/2024 |
| Daniel F. Sansone | ▲ Buy | Grant | 4,393 | $0 | 6/11/2024 |
| Sharon Spurlin | ▲ Buy | Grant | 4,393 | $0 | 6/11/2024 |
| Achilles B. Kintiroglou | ▼ Sell | Open Market | 350 | $8K | 6/3/2024 |
| Achilles B. Kintiroglou | ▼ Sell | Open Market | 3,661 | $92K | 5/1/2024 |
| Erin N. Kane | ▼ Sell | Open Market | 3,002 | $84K | 4/4/2024 |
| Erin N. Kane | ▼ Sell | Open Market | 613 | $17K | 4/2/2024 |
| Achilles B. Kintiroglou | ▼ Sell | Open Market | 3,900 | $108K | 4/1/2024 |
| Achilles B. Kintiroglou | ▼ Sell | Open Market | 100 | $3K | 4/1/2024 |
| Erin N. Kane | ▼ Sell | Open Market | 1,385 | $39K | 4/1/2024 |
| Erin N. Kane | ▼ Sell | Open Market | 5,000 | $142K | 3/28/2024 |
| Patrick Williams | ▲ Buy | Grant | 458 | $13K | 3/28/2024 |
| Todd D. Karran | ▲ Buy | Grant | 1,660 | $47K | 3/28/2024 |
| Achilles B. Kintiroglou | ▼ Sell | Open Market | 4,000 | $111K | 3/1/2024 |
| Preston Michael | ▼ Sell | Tax Withholding | 14,488 | $396K | 2/28/2024 |
| Kelly Slieter | ▲ Buy | Grant | 11,862 | $0 | 2/28/2024 |
| Achilles B. Kintiroglou | ▲ Buy | Grant | 15,047 | $0 | 2/28/2024 |
| Christopher Gramm | ▼ Sell | Tax Withholding | 4,800 | $131K | 2/28/2024 |
| Erin N. Kane | ▼ Sell | Tax Withholding | 54,328 | $1.5M | 2/28/2024 |
| Erin N. Kane | ▲ Buy | Grant | 63,962 | $0 | 2/28/2024 |
| Christopher Gramm | ▲ Buy | Grant | 5,391 | $0 | 2/28/2024 |
| Preston Michael | ▲ Buy | Grant | 28,323 | $0 | 2/28/2024 |
| Kelly Slieter | ▼ Sell | Tax Withholding | 5,648 | $155K | 2/28/2024 |
| Kelly Slieter | ▲ Buy | Grant | 11,513 | $0 | 2/28/2024 |
| Achilles B. Kintiroglou | ▼ Sell | Tax Withholding | 7,411 | $203K | 2/28/2024 |
| Achilles B. Kintiroglou | ▲ Buy | Grant | 16,046 | $0 | 2/28/2024 |
| Erin N. Kane | ▲ Buy | Grant | 106,213 | $0 | 2/28/2024 |
| Preston Michael | ▲ Buy | Grant | 14,620 | $0 | 2/28/2024 |
| Christopher Gramm | ▲ Buy | Grant | 10,445 | $0 | 2/28/2024 |
| Christopher Gramm | ▼ Sell | Tax Withholding | 1,317 | $37K | 2/24/2024 |
| Erin N. Kane | ▼ Sell | Tax Withholding | 13,596 | $378K | 2/24/2024 |
| Preston Michael | ▼ Sell | Tax Withholding | 3,745 | $104K | 2/24/2024 |
| Kelly Slieter | ▼ Sell | Tax Withholding | 1,562 | $43K | 2/24/2024 |
| Achilles B. Kintiroglou | ▼ Sell | Tax Withholding | 3,785 | $105K | 2/24/2024 |
| Achilles B. Kintiroglou | ▼ Sell | Open Market | 500 | $15K | 1/2/2024 |
| Achilles B. Kintiroglou | ▼ Sell | Open Market | 1,000 | $30K | 12/18/2023 |
| Patrick Williams | ▲ Buy | Grant | 447 | $13K | 12/15/2023 |
| Todd D. Karran | ▲ Buy | Grant | 1,617 | $47K | 12/15/2023 |
| Achilles B. Kintiroglou | ▼ Sell | Open Market | 500 | $15K | 10/2/2023 |
| Patrick Williams | ▲ Buy | Grant | 422 | $13K | 9/29/2023 |
| Todd D. Karran | ▲ Buy | Grant | 1,528 | $47K | 9/29/2023 |
| Achilles B. Kintiroglou | ▼ Sell | Open Market | 500 | $17K | 9/1/2023 |
| Achilles B. Kintiroglou | ▼ Sell | Open Market | 3,335 | $132K | 8/1/2023 |
| Christopher Gramm | ▼ Sell | Open Market | 1,000 | $37K | 7/17/2023 |
| Achilles B. Kintiroglou | ▼ Sell | Open Market | 3,335 | $116K | 7/3/2023 |
| Todd D. Karran | ▲ Buy | Grant | 851 | $30K | 6/30/2023 |
| Patrick Williams | ▲ Buy | Grant | 393 | $14K | 6/30/2023 |
| Kelly Slieter | ▼ Sell | Tax Withholding | 4,535 | $156K | 6/24/2023 |
| Christopher Gramm | ▼ Sell | Open Market | 1,000 | $36K | 6/16/2023 |
| Todd D. Karran | ▲ Buy | Grant | 2,975 | $0 | 6/15/2023 |
| Daniel F. Sansone | ▲ Buy | Grant | 2,975 | $0 | 6/15/2023 |
| Gena C. Lovett | ▲ Buy | Grant | 2,975 | $0 | 6/15/2023 |
| Hughes Darrell K. | ▲ Buy | Grant | 2,975 | $0 | 6/15/2023 |
| Sharon Spurlin | ▲ Buy | Grant | 2,975 | $0 | 6/15/2023 |
| Patrick Williams | ▲ Buy | Grant | 2,975 | $0 | 6/15/2023 |
| Farha Aslam | ▲ Buy | Grant | 2,975 | $0 | 6/15/2023 |
| Achilles B. Kintiroglou | ▼ Sell | Open Market | 3,335 | $118K | 6/12/2023 |
| Christopher Gramm | ▼ Sell | Open Market | 1,000 | $35K | 5/19/2023 |
| Christopher Gramm | ▼ Sell | Open Market | 1,000 | $40K | 4/17/2023 |
| Marberry Michael | ▲ Buy | Grant | 620 | $24K | 3/31/2023 |
| Patrick Williams | ▲ Buy | Grant | 293 | $11K | 3/31/2023 |
| Todd D. Karran | ▲ Buy | Grant | 685 | $26K | 3/31/2023 |
| Christopher Gramm | ▼ Sell | Open Market | 1,000 | $35K | 3/16/2023 |
| Preston Michael | ▲ Buy | Grant | 4,854 | $0 | 2/28/2023 |
| Preston Michael | ▲ Buy | Grant | 56,845 | $0 | 2/28/2023 |
| Preston Michael | ▼ Sell | Tax Withholding | 28,946 | $1.2M | 2/28/2023 |
| Achilles B. Kintiroglou | ▼ Sell | Tax Withholding | 14,792 | $609K | 2/28/2023 |
| Achilles B. Kintiroglou | ▲ Buy | Grant | 4,095 | $0 | 2/28/2023 |
| Erin N. Kane | ▲ Buy | Grant | 187,586 | $0 | 2/28/2023 |
| Erin N. Kane | ▼ Sell | Tax Withholding | 95,755 | $3.9M | 2/28/2023 |
| Achilles B. Kintiroglou | ▲ Buy | Grant | 30,200 | $0 | 2/28/2023 |
| Christopher Gramm | ▲ Buy | Grant | 20,962 | $0 | 2/28/2023 |
| Christopher Gramm | ▼ Sell | Tax Withholding | 9,388 | $387K | 2/28/2023 |
| Christopher Gramm | ▲ Buy | Grant | 1,790 | $0 | 2/28/2023 |
| Kelly Slieter | ▲ Buy | Grant | 2,942 | $0 | 2/28/2023 |
| Erin N. Kane | ▲ Buy | Grant | 6,007 | $0 | 2/28/2023 |
| Preston Michael | ▼ Sell | Tax Withholding | 7,475 | $307K | 2/26/2023 |
| Achilles B. Kintiroglou | ▼ Sell | Tax Withholding | 3,733 | $153K | 2/26/2023 |
| Erin N. Kane | ▼ Sell | Tax Withholding | 24,194 | $994K | 2/26/2023 |
| Christopher Gramm | ▼ Sell | Tax Withholding | 5,767 | $237K | 2/26/2023 |
| Achilles B. Kintiroglou | ▼ Sell | Tax Withholding | 1,905 | $78K | 2/24/2023 |
| Christopher Gramm | ▼ Sell | Open Market | 2,000 | $84K | 2/23/2023 |
| Patrick Williams | ▲ Buy | Grant | 290 | $11K | 12/15/2022 |
| Marberry Michael | ▲ Buy | Grant | 565 | $22K | 12/15/2022 |
| Hughes Darrell K. | ▲ Buy | Grant | 203 | $8K | 12/15/2022 |
| Christopher Gramm | ▼ Sell | Open Market | 1,000 | $40K | 12/15/2022 |
| Todd D. Karran | ▲ Buy | Grant | 677 | $26K | 12/15/2022 |
| Christopher Gramm | ▼ Sell | Open Market | 1,000 | $40K | 11/15/2022 |
| Christopher Gramm | ▼ Sell | Open Market | 1,000 | $33K | 10/17/2022 |
| Patrick Williams | ▲ Buy | Grant | 351 | $11K | 9/30/2022 |
| Hughes Darrell K. | ▲ Buy | Grant | 245 | $8K | 9/30/2022 |
| Marberry Michael | ▲ Buy | Grant | 681 | $22K | 9/30/2022 |
| Todd D. Karran | ▲ Buy | Grant | 818 | $26K | 9/30/2022 |
| Christopher Gramm | ▼ Sell | Open Market | 1,000 | $34K | 9/15/2022 |
| Christopher Gramm | ▼ Sell | Open Market | 1,000 | $39K | 8/15/2022 |
| Christopher Gramm | ▼ Sell | Open Market | 1,000 | $34K | 7/15/2022 |
| Patrick Williams | ▲ Buy | Grant | 336 | $11K | 6/30/2022 |
| Marberry Michael | ▲ Buy | Grant | 655 | $22K | 6/30/2022 |
| Hughes Darrell K. | ▲ Buy | Grant | 236 | $8K | 6/30/2022 |
| Todd D. Karran | ▲ Buy | Grant | 754 | $25K | 6/30/2022 |
| Kelly Slieter | ▼ Sell | Tax Withholding | 4,456 | $147K | 6/24/2022 |
| Patrick Williams | ▲ Buy | Grant | 2,714 | $0 | 6/15/2022 |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 25, 2026
AdvanSix Featured in Chemical Stocks With Natural Gas Cost Edge
AdvanSix (ASIX) was included in a recent article highlighting three US chemical stocks that benefit from lower natural gas costs. This cost advantage is relevant to the company's production expenses in the specialty chemicals sector. The stock is currently trading below its average analyst target price, with a 52-week range extending from $14.10 to $26.73.
AdvanSix Featured in Chemical Stocks With Natural Gas Cost Edge. AdvanSix (ASIX) was included in a recent article highlighting three US chemical stocks that benefit from lower natural gas costs. This cost advantage is relevant to the company's production expenses in the specialty chemicals sector. The stock is currently trading below its average analyst target price, with a 52-week range extending from $14.10 to $26.73.